Clinical trials: Executive Function Deficits (EFD's)

ADHD, Executive Function Deficits (EFD's)

Memantine Monotherapy for Executive Dysfunction and ADHD

• Withdrawn
• Age: 18 to 45 years

This is a 12-week clinical trial evaluating the efficacy and safety of memantine hydrochloride (Memantine HC1, brand name Namenda) in the treatment of executive function deficits (EFDs) in adults with Attention Deficit…

Trial name

NCT01844427

Testing

Memantine

Sponsor

Massachusetts General Hospital